This country profile provides an overview of Madagascar’s progress in reaching those in need of mass NTD treatment based on 2018 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Treatment coverage remained at 0% in 2017 and 2018.
Madagascar does not require mass treatment for blinding trachoma.
Treatment coverage decreased from 65% in 2017 to 0% in 2018.
Treatment coverage decreased from 100% in 2017 to 0% in 2018.
Madagascar does not require mass treatment for river blindness.
The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Madagascar.